|
AB Science: Web conference on masitinib in asthma – Safety and Efficacy Update
GlobeNewswire (press release) Paris, France, Nov. 25, 2014 (GLOBE NEWSWIRE) — AB Science SA (NYSE Euronext – FR0010557264 – AB), a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), is hosting a web … |
View full post on asthma – Google News